TABLE 3:

Neurologic response to IA nicardipine with or without angioplasty

Case^*	Postbleeding Day	Vessel	Nicardipine (mg)	Vasospasm	Post-Treatment Neurologic Examination
2	7	R MCA	3	Mild	Yes
		R ACA	2	Mild
4	7	BA	5	Moderate	No
5	4	R ICA	5	Mild	Yes
		L ICA	5	Moderate
		L Vert	5	Moderate
6	7	L ICA	5	Severe	No
7	6	R ICA	5	Moderate	No
		BA	3	Moderate
9	12	R ACA	5	Moderate	No
		L ACA	5	Moderate
10	4	L ICA	5	Moderate	Yes
11	6	L MCA		Moderate	Yes
12	6	R ICA	2	Moderate	No
		L ICA	3	Moderate
13	13	R ICA	5	Moderate
		L ICA	2.5	Mild
14	11	L Vert	5	Mild	No
15	14	L ICA	2.5	Mild	No
19	6	R ICA	2	Mild	Yes
		L ACA	4	Severe
20	10	L ACA	4	Severe	Yes
		L MCA	4	Severe
		R MCA	4	Severe
		R ACA	4	Severe
21	4	L MCA	3	Mild	No
		L MCA	3	Mild
		L ACA	3	Mild
	6	R ICA	4	Severe	No
		L ICA	2	Mild
22	8	L ICA	2	Mild	No
		L PCA	1	Moderate
23	9	R ACA	3	Mild	Yes
24	7	L ICA	4	Mild	Yes

Note.—ACA = anterior cerebral artery, BA = basilar artery, MCA = middle cerebral artery, PCA = posterior cerebral artery, Vert = vertebral artery.
* Case 1 involved the use of papaverine and was not included.